1sthealthcenters - Pediatrics

Pediatric RSV Vaccination

Description: RSV followed by parainfluenza virus is the leading cause of lower respiratory tract infection in children world wide. IMMUNOe International Research Centers are conducting a research study to evaluate an investigational nasal vaccine spray to see if it can prevent RSV and parainfluenza virus in young children.

Qualifications Include:
- 6- 24 months of age
- Generally Healthy
- Available for all study visits and telephone calls

The duration of this study is one year. All study related vaccines and visits will be provided at no cost. Participants may be compensated for their time and travel.

For further information contact our study coordinator at 303.773.9000 or email jrobbins@immunoe.com

IMMUNOe Health Centers
6801 S. Yosemite Street
Centennial, CO 80112
303.773.9000

Click here to volunteer for a research study.

Gastroesophageal Reflux Disease (GERD)

Description: Gastroesophageal Reflux Disease (GERD) is when stomach contents (stomach acid and/or bile) come back up the esophagus and can cause inflammation or damage to the tissue. This is a result of improper closure of the valve at the top of the stomach.

Current Therapies: Current therapies for this age group include primarily with proton pump inhibitors and H2-blockers. The current therapies are metabolized by a very common pathway and can result in various drug interactions and increased or decreased metabolism of other medications.

Objective: To evaluate the efficacy and safety of an investigational pediatric micro-bead formulation of rabeprazole sodium 2 target dose levels in subjects 1-11 years of age with endoscopically proven GERD.

Study Length: Part 1: 14 weeks, Part 2: 24 weeks

Randomization: Double-blind, randomized to study drug 0.5mg/kg or 1.0mg/kg in a 1:1 ratio

Number of visits: Part 1: 5 in office visits and 2 telephone callsPart 2: 4 in office visits Visit content: Blood draws, pregnancy test (if applicable), EGD with biopsy, pHmetry (if indicated), physical assessments, treatment and symptom surveys/scales

Patient Responsibilities: Patient caregiver must complete an e-diary during the entire study.

Major Inclusions:
- Male or female age 1-11 years
- History of at least 1 GERD symptom within 3 months prior to screening
- Positive EGD during screening

Major Exclusions:
- History of eosinophilic esophagitis
- Have taken PPIs or H2-blockers within 3 days of random assignment
- Have taken sucralfate or any medication affecting GI motility including caffeine within 3 days before study entry
- H.pylori infection
- Current patrticipation or participation in the last 30 days in an investigational drug trial

Participants may receive study medication and physical assessments at no cost during the study. Participants who complete the entire study will be compensated $30 per completed study visit.

For further information call 303.773.9000, or email jrobbins@immunoe.com or kmartinez@immunoe.com
IMMUNOe Health Centers
6801 S. Yosemite Street
Centennial, CO 80112
303.773.9000

Click here to volunteer for a research study.

Pediatric Migraine

Description: If your child has a history of migraines, he or she may qualify for a research study of an investigational medication for pediatric migraines.

Qualifications Include:

- Between 12- 17 years old

- History of migraines for more than 6 months

- Available for study

Qualified participants will receive study related medication and study related vists at no cost. Health insurance is not needed. Participants may be compensated for time and travel.

For more information please call 303.773.9000, or email shill@immunoe.com or czimbleman@immunoe.com

NEWS:

Download forms prior to your first visit. >>

CONTACT US
Phone: Fax: Email:	(303) 773-9000 or (877) 270-0491 (303) 770-1449 Click here >>
Locations:		South Office >> North Office >>